Financhill
Buy
54

CLOV Quote, Financials, Valuation and Earnings

Last price:
$3.35
Seasonality move :
50.4%
Day range:
$3.32 - $3.40
52-week range:
$0.63 - $4.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.27x
P/B ratio:
5.09x
Volume:
3.6M
Avg. volume:
5.4M
1-year change:
439.68%
Market cap:
$1.7B
Revenue:
$1.4B
EPS (TTM):
-$0.09

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CLOV
Clover Health Investments
$466.9M -$0.07 34.59% -75% $4.75
ALHC
Alignment Healthcare
$888.3M -$0.07 41.56% -84% $17.78
CNC
Centene
$43.2B $2.52 10.95% -2.35% $77.84
ELV
Elevance Health
$46.2B $11.48 10.81% -3.97% $505.55
OSCR
Oscar Health
$2.9B $0.81 32.34% 45.16% $19.36
PGNY
Progyny
$307.8M $0.45 11.16% 161.18% $26.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CLOV
Clover Health Investments
$3.40 $4.75 $1.7B -- $0.00 0% 1.27x
ALHC
Alignment Healthcare
$17.72 $17.78 $3.4B -- $0.00 0% 1.25x
CNC
Centene
$59.85 $77.84 $29.8B 8.92x $0.00 0% 0.18x
ELV
Elevance Health
$420.58 $505.55 $95B 16.41x $1.71 1.57% 0.53x
OSCR
Oscar Health
$13.01 $19.36 $3.3B -- $0.00 0% 0.39x
PGNY
Progyny
$22.84 $26.75 $2B 40.07x $0.00 0% 1.89x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CLOV
Clover Health Investments
-- 3.602 -- 1.47x
ALHC
Alignment Healthcare
76.3% 1.920 14.89% 1.78x
CNC
Centene
39.62% -0.071 60.45% 1.07x
ELV
Elevance Health
41.38% 0.282 30.53% 2.01x
OSCR
Oscar Health
22.81% 2.511 8.89% 0.96x
PGNY
Progyny
-- -0.288 -- 2.75x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CLOV
Clover Health Investments
$93.9M -$21.4M -13.55% -13.55% -6.38% -$86.1M
ALHC
Alignment Healthcare
$86.3M -$22.5M -37.65% -101.38% -3.65% -$18M
CNC
Centene
$5.2B $1.5B 7.62% 12.65% 4.11% $1.4B
ELV
Elevance Health
-- -- 8.37% 14.03% 6.43% $821M
OSCR
Oscar Health
-- -- 1.91% 2.46% -6.17% $340M
PGNY
Progyny
$63.4M $15.8M 11.14% 11.14% 5.29% $50.3M

Clover Health Investments vs. Competitors

  • Which has Higher Returns CLOV or ALHC?

    Alignment Healthcare has a net margin of -6.56% compared to Clover Health Investments's net margin of -4.43%. Clover Health Investments's return on equity of -13.55% beat Alignment Healthcare's return on equity of -101.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLOV
    Clover Health Investments
    27.87% -$0.04 $341.1M
    ALHC
    Alignment Healthcare
    12.31% -$0.16 $422.4M
  • What do Analysts Say About CLOV or ALHC?

    Clover Health Investments has a consensus price target of $4.75, signalling upside risk potential of 39.71%. On the other hand Alignment Healthcare has an analysts' consensus of $17.78 which suggests that it could grow by 0.33%. Given that Clover Health Investments has higher upside potential than Alignment Healthcare, analysts believe Clover Health Investments is more attractive than Alignment Healthcare.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLOV
    Clover Health Investments
    2 2 0
    ALHC
    Alignment Healthcare
    6 3 0
  • Is CLOV or ALHC More Risky?

    Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Alignment Healthcare has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CLOV or ALHC?

    Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alignment Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments pays -- of its earnings as a dividend. Alignment Healthcare pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLOV or ALHC?

    Clover Health Investments quarterly revenues are $337M, which are smaller than Alignment Healthcare quarterly revenues of $701.2M. Clover Health Investments's net income of -$22.1M is higher than Alignment Healthcare's net income of -$31.1M. Notably, Clover Health Investments's price-to-earnings ratio is -- while Alignment Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 1.27x versus 1.25x for Alignment Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLOV
    Clover Health Investments
    1.27x -- $337M -$22.1M
    ALHC
    Alignment Healthcare
    1.25x -- $701.2M -$31.1M
  • Which has Higher Returns CLOV or CNC?

    Centene has a net margin of -6.56% compared to Clover Health Investments's net margin of 2.81%. Clover Health Investments's return on equity of -13.55% beat Centene's return on equity of 12.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLOV
    Clover Health Investments
    27.87% -$0.04 $341.1M
    CNC
    Centene
    11.16% $2.63 $46.3B
  • What do Analysts Say About CLOV or CNC?

    Clover Health Investments has a consensus price target of $4.75, signalling upside risk potential of 39.71%. On the other hand Centene has an analysts' consensus of $77.84 which suggests that it could grow by 30.07%. Given that Clover Health Investments has higher upside potential than Centene, analysts believe Clover Health Investments is more attractive than Centene.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLOV
    Clover Health Investments
    2 2 0
    CNC
    Centene
    7 8 0
  • Is CLOV or CNC More Risky?

    Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene has a beta of 0.478, suggesting its less volatile than the S&P 500 by 52.18%.

  • Which is a Better Dividend Stock CLOV or CNC?

    Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLOV or CNC?

    Clover Health Investments quarterly revenues are $337M, which are smaller than Centene quarterly revenues of $46.6B. Clover Health Investments's net income of -$22.1M is lower than Centene's net income of $1.3B. Notably, Clover Health Investments's price-to-earnings ratio is -- while Centene's PE ratio is 8.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 1.27x versus 0.18x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLOV
    Clover Health Investments
    1.27x -- $337M -$22.1M
    CNC
    Centene
    0.18x 8.92x $46.6B $1.3B
  • Which has Higher Returns CLOV or ELV?

    Elevance Health has a net margin of -6.56% compared to Clover Health Investments's net margin of 4.47%. Clover Health Investments's return on equity of -13.55% beat Elevance Health's return on equity of 14.03%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLOV
    Clover Health Investments
    27.87% -$0.04 $341.1M
    ELV
    Elevance Health
    -- $9.61 $72.6B
  • What do Analysts Say About CLOV or ELV?

    Clover Health Investments has a consensus price target of $4.75, signalling upside risk potential of 39.71%. On the other hand Elevance Health has an analysts' consensus of $505.55 which suggests that it could grow by 20.2%. Given that Clover Health Investments has higher upside potential than Elevance Health, analysts believe Clover Health Investments is more attractive than Elevance Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLOV
    Clover Health Investments
    2 2 0
    ELV
    Elevance Health
    13 4 0
  • Is CLOV or ELV More Risky?

    Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.296%.

  • Which is a Better Dividend Stock CLOV or ELV?

    Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.57% to investors and pays a quarterly dividend of $1.71 per share. Clover Health Investments pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CLOV or ELV?

    Clover Health Investments quarterly revenues are $337M, which are smaller than Elevance Health quarterly revenues of $48.9B. Clover Health Investments's net income of -$22.1M is lower than Elevance Health's net income of $2.2B. Notably, Clover Health Investments's price-to-earnings ratio is -- while Elevance Health's PE ratio is 16.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 1.27x versus 0.53x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLOV
    Clover Health Investments
    1.27x -- $337M -$22.1M
    ELV
    Elevance Health
    0.53x 16.41x $48.9B $2.2B
  • Which has Higher Returns CLOV or OSCR?

    Oscar Health has a net margin of -6.56% compared to Clover Health Investments's net margin of -6.42%. Clover Health Investments's return on equity of -13.55% beat Oscar Health's return on equity of 2.46%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLOV
    Clover Health Investments
    27.87% -$0.04 $341.1M
    OSCR
    Oscar Health
    -- -$0.62 $1.3B
  • What do Analysts Say About CLOV or OSCR?

    Clover Health Investments has a consensus price target of $4.75, signalling upside risk potential of 39.71%. On the other hand Oscar Health has an analysts' consensus of $19.36 which suggests that it could grow by 48.79%. Given that Oscar Health has higher upside potential than Clover Health Investments, analysts believe Oscar Health is more attractive than Clover Health Investments.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLOV
    Clover Health Investments
    2 2 0
    OSCR
    Oscar Health
    1 2 1
  • Is CLOV or OSCR More Risky?

    Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CLOV or OSCR?

    Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments pays -- of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLOV or OSCR?

    Clover Health Investments quarterly revenues are $337M, which are smaller than Oscar Health quarterly revenues of $2.4B. Clover Health Investments's net income of -$22.1M is higher than Oscar Health's net income of -$153.5M. Notably, Clover Health Investments's price-to-earnings ratio is -- while Oscar Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 1.27x versus 0.39x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLOV
    Clover Health Investments
    1.27x -- $337M -$22.1M
    OSCR
    Oscar Health
    0.39x -- $2.4B -$153.5M
  • Which has Higher Returns CLOV or PGNY?

    Progyny has a net margin of -6.56% compared to Clover Health Investments's net margin of 3.53%. Clover Health Investments's return on equity of -13.55% beat Progyny's return on equity of 11.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLOV
    Clover Health Investments
    27.87% -$0.04 $341.1M
    PGNY
    Progyny
    21.26% $0.12 $422.1M
  • What do Analysts Say About CLOV or PGNY?

    Clover Health Investments has a consensus price target of $4.75, signalling upside risk potential of 39.71%. On the other hand Progyny has an analysts' consensus of $26.75 which suggests that it could grow by 17.12%. Given that Clover Health Investments has higher upside potential than Progyny, analysts believe Clover Health Investments is more attractive than Progyny.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLOV
    Clover Health Investments
    2 2 0
    PGNY
    Progyny
    4 6 0
  • Is CLOV or PGNY More Risky?

    Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny has a beta of 1.372, suggesting its more volatile than the S&P 500 by 37.195%.

  • Which is a Better Dividend Stock CLOV or PGNY?

    Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CLOV or PGNY?

    Clover Health Investments quarterly revenues are $337M, which are larger than Progyny quarterly revenues of $298.4M. Clover Health Investments's net income of -$22.1M is lower than Progyny's net income of $10.5M. Notably, Clover Health Investments's price-to-earnings ratio is -- while Progyny's PE ratio is 40.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 1.27x versus 1.89x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLOV
    Clover Health Investments
    1.27x -- $337M -$22.1M
    PGNY
    Progyny
    1.89x 40.07x $298.4M $10.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Is Okta Stock Finally Gaining Investor Confidence?
Is Okta Stock Finally Gaining Investor Confidence?

Given how digital transformation has proliferated, cyberattacks have also been…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Sell
50
RGC alert for May 1

Regencell Bioscience Holdings [RGC] is up 5.53% over the past day.

Sell
38
WGS alert for May 1

GeneDx Holdings [WGS] is down 2.32% over the past day.

Sell
43
VICR alert for May 1

Vicor [VICR] is up 0.58% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock